CID Vascular Sponsors Tech News & Trends at Euro PCR 2010

PARIS, May 26, 2010 - CID Vascular, a leader in interventional medicine, is sponsoring Tech
News & Trends at Euro PCR on May 26th in Paris. The two-hour session will
explore issues surrounding the complex decisions doctors must make when
implanting coronary stents in patients with conditions that affect blood
clotting.

Two live cases performed by Drs. Antonio Colombo and Giuseppe De Luca
will be beamed by satellite from Milan, into the convention hall in Paris for
viewing by doctors attending the meeting. "Placing a stent in patients with
coronary heart disease is just the beginning of their treatment. These
patients need careful screening for the appropriate strategy to be applied,
which includes device and drug therapies that optimize clinical outcomes.
This is especially difficult in patients who cannot easily tolerate the
medicines that are usually given for up to a year or more following a
procedure," said Dr. Colombo of San Rafaelle Hospital, Milan, Italy.

The Optima Jet, drug-eluting stent with its Carbofilm coating and
abluminal reservoir technology, has been selected for patients with a high
risk of bleeding and the AvanteGarde due to its anti-thrombogenic properties
for patients with high risk of thrombosis. "We create our stents knowing that
they must continue to provide patients with the best results and safety
throughout their lives and we are very proud of our track record," said
Franco Vallana, Chief Executive Officer of CID Vascular.

For more information on CID Vascular: www.cidvascular.com

For more information on CID Vascular contact: Info at cidvascular.com, +39-0161-487338